Motley Fool Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.7M | Sell |
112,527
-18,768
| -14% | -$2.63M | 0.67% | 26 |
|
|
2025
Q4 | $16.1M | Buy |
131,295
+29,394
| +29% | +$3.57M | 0.63% | 36 |
|
|
2025
Q3 | $11.3M | Buy |
101,901
+20,647
| +25% | +$2.35M | 0.47% | 42 |
|
|
2025
Q2 | $9.01M | Buy |
81,254
+10,554
| +15% | +$1.12M | 0.42% | 48 |
|
|
2025
Q1 | $7.92M | Buy |
70,700
+3,597
| +5% | +$371K | 0.44% | 49 |
|
|
2024
Q4 | $6.2M | Buy |
67,103
+8,678
| +15% | +$781K | 0.32% | 68 |
|
|
2024
Q3 | $4.9M | Buy |
58,425
+3,348
| +6% | +$255K | 0.29% | 79 |
|
|
2024
Q2 | $3.78M | Buy |
55,077
+12,500
| +29% | +$834K | 0.25% | 80 |
|
|
2024
Q1 | $3.12M | Buy |
42,577
+5,068
| +14% | +$390K | 0.2% | 90 |
|
|
2023
Q4 | $3.04M | Buy |
37,509
+2,135
| +6% | +$166K | 0.23% | 88 |
|
|
2023
Q3 | $2.65M | Buy |
35,374
+2,975
| +9% | +$229K | 0.21% | 86 |
|
|
2023
Q2 | $2.5M | Buy |
32,399
+2,133
| +7% | +$170K | 0.22% | 82 |
|
|
2023
Q1 | $2.51M | Buy |
30,266
+2,619
| +9% | +$217K | 0.28% | 73 |
|
|
2022
Q4 | $2.37M | Sell |
27,647
-1,204
| -4% | -$95.3K | 0.27% | 80 |
|
|
2022
Q3 | $1.78M | Sell |
28,851
-177
| -0.6% | -$11.2K | 0.17% | 94 |
|
|
2022
Q2 | $1.81M | Sell |
29,028
-2,104
| -7% | -$130K | 0.17% | 98 |
|
|
2022
Q1 | $1.85M | Sell |
31,132
-1,210
| -4% | -$77.3K | 0.14% | 108 |
|
|
2021
Q4 | $2.35M | Buy |
32,342
+1,163
| +4% | +$80.1K | 0.15% | 102 |
|
|
2021
Q3 | $2.18M | Buy |
31,179
+456
| +1% | +$32K | 0.14% | 105 |
|
|
2021
Q2 | $2.12M | Buy |
30,723
+3,141
| +11% | +$210K | 0.14% | 107 |
|
|
2021
Q1 | $1.78M | Sell |
27,582
-2,318
| -8% | -$149K | 0.13% | 102 |
|
|
2020
Q4 | $1.74M | Buy |
29,900
+1,615
| +6% | +$97.5K | 0.13% | 100 |
|
|
2020
Q3 | $1.79M | Buy |
28,285
+4,898
| +21% | +$340K | 0.16% | 91 |
|
|
2020
Q2 | $1.8M | Buy |
23,387
+945
| +4% | +$72.4K | 0.18% | 84 |
|
|
2020
Q1 | $1.68M | Sell |
22,442
-113
| -0.5% | -$7.81K | 0.22% | 77 |
|
|
2019
Q4 | $1.47M | Sell |
22,555
-1,006
| -4% | -$65.5K | 0.16% | 88 |
|
|
2019
Q3 | $1.49M | Buy |
23,561
+1,721
| +8% | +$113K | 0.17% | 88 |
|
|
2019
Q2 | $1.48M | Buy |
21,840
+722
| +3% | +$47.5K | 0.16% | 88 |
|
|
2019
Q1 | $1.37M | Buy |
21,118
+3,871
| +22% | +$257K | 0.16% | 94 |
|
|
2018
Q4 | $1.08M | Buy |
17,247
+1,511
| +10% | +$106K | 0.15% | 95 |
|
|
2018
Q3 | $1.22M | Buy |
15,736
+2,364
| +18% | +$179K | 0.15% | 85 |
|
|
2018
Q2 | $947K | Buy |
13,372
+796
| +6% | +$56.2K | 0.13% | 91 |
|
|
2018
Q1 | $948K | Buy |
+12,576
| New | +$1,000K | 0.13% | 85 |
|
Other funds holding GILD
VCM
VPM
Motley Fool Asset Management's GILD Position: Q1 2026 in Review
Motley Fool Asset Management reduced its Gilead Sciences (GILD) stake by 14% in Q1 2026, selling an estimated $2.63M and leaving 112,527 shares worth $15.7M. The position accounts for 0.67% of the portfolio, ranked #26.
Motley Fool Asset Management first reported a position in GILD in Q1 2018 and has held it in 33 quarters since. The position peaked at $16.1M in Q4 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Motley Fool Asset Management held 112,527 shares of Gilead Sciences worth $15.7M as of Q1 2026.
- Motley Fool Asset Management sold 18,768 Gilead Sciences shares in Q1 2026, an estimated $2.63M.
- Gilead Sciences made up 0.67% of Motley Fool Asset Management's portfolio in Q1 2026, its #26 holding.
- Motley Fool Asset Management first reported a position in Gilead Sciences in Q1 2018 and has held it in 33 quarters since.
- Motley Fool Asset Management's Gilead Sciences position peaked at $16.1M in Q4 2025.
- 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Motley Fool Asset Management's 13F filing for Q1 2026, filed 12 May 2026.